Merlin Biosciences Limited is a specialised venture investor in life sciences companies managing three funds, Merlin Fund (Fund I), Merlin Biosciences Fund (Fund II) and Merlin Biosciences Fund III (Fund III), worth in excess of €450 million of equity capital. Merlin invests in companies that are bringing to market human medicines or medical devices with groundbreaking technology and significant commercial potential. Since 1997, Merlin has participated in the funding of 35 European biotechnology and life science companies on behalf of its investment partnerships. Leveraging a worldwide, dedicated network of advisers and experienced strategic partners, Merlin has built a reputation for being an exceptional partner for management teams who can create substantial value for investors.